Nuclear Medicine Market Size, Share, Growth & Industry Analysis, By Product (Diagnostic, Therapeutic), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-user (Hospitals & Clinics, Diagnostics Centers, Others) and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL NUCLEAR MEDICINE MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL NUCLEAR MEDICINE MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL NUCLEAR MEDICINE MARKET, BY PRODUCT
6.1 Overview
6.2 Diagnostic
6.3 Therapeutic 

7 GLOBAL NUCLEAR MEDICINE MARKET, BY APPLICATION
7.1 Overview
7.2 Cardiology
7.3 Neurology
7.4 Oncology
7.5 Thyroid
7.6 Lymphoma
7.7 Bone Metastasis
7.8 Endocrine Tumor
7.9 Others

8 GLOBAL NUCLEAR MEDICINE MARKET, BY END-USER
8.1 Overview
8.2 Hospitals & Clinics
8.3 Diagnostics Centers
8.4 Others

9 GLOBAL NUCLEAR MEDICINE MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Siemens Healthineers AG
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Novartis AG
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 CURIUM PHARMA
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Cambridge Isotope Laboratories Inc.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Cardinal Health Inc
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 GE Healthcare
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Nordion Inc
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8  Merck KGaA
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 Lantheus Holdings, Inc
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 Bracco S.p.A.
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 2 Global Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 3 Global Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 4 Global Nuclear Medicine Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 5 North America Nuclear Medicine Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 6 North America Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 7 North America Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 8 North America Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 9 US Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 10 US Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 11 US Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 12 Canada Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 13 Canada Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 14 Canada Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 15 Mexico Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 16 Mexico Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 17 Mexico Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 18 Europe Nuclear Medicine Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 19 Europe Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 20 Europe Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 21 Europe Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 22 Germany Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 23 Germany Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 24 Germany Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 25 France Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 26 France Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 27 France Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 28 U.K. Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 29 U.K. Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 30 U.K. Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 31 Spain Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 32 Spain Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 33 Spain Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 34 Italy Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 35 Italy Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 36 Italy Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 37 Russia Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 38 Russia Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 39 Russia Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 40 Rest of Europe Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 41 Rest of Europe Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 42 Rest of Europe Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 43 Asia-Pacific Nuclear Medicine Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 44 Asia-Pacific Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 45 Asia-Pacific Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 46 Asia-Pacific Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 47 China Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 48 China Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 49 China Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 50 Japan Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 51 Japan Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 52 Japan Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 53 India Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 54 India Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 55 India Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 56 South Korea Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 57 South Korea Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 58 South Korea Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 59 Rest of Asia-Pacific Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 60 Rest of Asia-Pacific Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 61 Rest of Asia-Pacific Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 62 Middle East and Africa Nuclear Medicine Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 63 Middle East and Africa Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 64 Middle East and Africa Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 65 Middle East and Africa Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 66 GCC Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 67 GCC Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 68 GCC Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 69 North Africa Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 70 North Africa Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 71 North Africa Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 72 South Africa Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 73 South Africa Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 74 South Africa Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 75 Rest of Middle East & Africa Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 76 Rest of Middle East & Africa Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 77 Rest of Middle East & Africa Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 78 Latin America Nuclear Medicine Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 79 Latin America Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 80 Latin America Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 81 Latin America Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 82 Brazil Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 83 Brazil Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 84 Brazil Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 85 Argentina Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 86 Argentina Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 87 Argentina Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 88 Rest of Latin America Nuclear Medicine Market Revenue, By Product, 2021 – 2031 (USD Million)
TABLE 89 Rest of Latin America Nuclear Medicine Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 90 Rest of Latin America Nuclear Medicine Market Revenue, By End-user, 2021 – 2031 (USD Million)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Nuclear Medicine Market 2021-2031 (USD Million)
FIG. 4 Global Nuclear Medicine Market Geographical Analysis (CAGR %)
FIG. 5 Global Nuclear Medicine Absolute Market Opportunity (USD Million)
FIG. 6 Global Nuclear Medicine Market Attractiveness (USD Million)
FIG. 7 Global Nuclear Medicine Market, By Product, 2021-2031 (USD Million)
FIG. 8 Global Nuclear Medicine Market, By Application, 2021-2031 (USD Million)
FIG. 9 Global Nuclear Medicine Market, By End-user, 2021-2031 (USD Million)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Nuclear Medicine Market Revenue Share, By Product, 2023 and 2031 (%)
FIG. 19 Global Nuclear Medicine Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 20 Global Nuclear Medicine Market Revenue Share, By End-user, 2023 and 2031 (%)
FIG. 21 Global Nuclear Medicine Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 North America Nuclear Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Europe Nuclear Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Asia-Pacific Nuclear Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Middle East & Africa Nuclear Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 31 Latin America Nuclear Medicine Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis